Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crinetics Pharmaceuticals Inc
(NQ:
CRNX
)
51.62
-0.91 (-1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crinetics Pharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
September 20, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?
September 19, 2023
Despite good results in phase 3 trials, there are barriers to its drug candidate's success.
Via
The Motley Fool
Why Crinetics Pharmaceuticals Stock Soared This Week
September 15, 2023
A positive late-stage trial readout fueled a major rally in the drugmaker's shares.
Via
The Motley Fool
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
September 12, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX) Near the Top of Equities by Percentage Gain on 9/11
September 11, 2023
Via
Investor Brand Network
9 Analysts Have This to Say About Crinetics Pharmaceuticals
August 31, 2023
Via
Benzinga
Analyst Expectations for Crinetics Pharmaceuticals's Future
August 09, 2023
Via
Benzinga
What's Going On With Crinetics Pharmaceuticals Stock?
September 12, 2023
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) shares are trading higher Tuesday.
Via
Benzinga
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
September 11, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
Nasdaq Rises Over 1%; Hostess Brands Shares Spike Higher
September 11, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
September 11, 2023
Via
Benzinga
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...
Via
Benzinga
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday
September 11, 2023
The biotech company reported positive phase 3 trial results.
Via
The Motley Fool
Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results
September 11, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crinetics Pharma's Investigational Candidate Shows Promise In Rare Type Of Hormonal Disorder
September 11, 2023
On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary
Via
Benzinga
Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 71%
September 11, 2023
The company is working on a treatment for a growth hormone disorder.
Via
Investor's Business Daily
US Stocks Open Higher; Dow Jumps 150 Points
September 11, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 34,736.26 while the NASDAQ rose 0.94% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Nuwellis (NUWE) Stock Down Today?
September 11, 2023
Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 11, 2023
Via
Benzinga
Why Is Tenon Medical (TNON) Stock Down 30% Today?
September 11, 2023
Tenon Medical (TNON) stock is falling on Monday after the surgical implant company announced a proposed public offering for its shares.
Via
InvestorPlace
Why Is Versus Systems (VS) Stock Up 17% Today?
September 11, 2023
Versus Systems (VS) stock is rising higher on Monday as the business software company's shares experience heavy trading this morning.
Via
InvestorPlace
Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket
September 11, 2023
Gainers
Via
Benzinga
Why Is Crinetics Pharmaceuticals (CRNX) Stock Up 64% Today?
September 11, 2023
Crinetics Pharmaceuticals (CRNX) stock is on the rise Monday after the company announced positive clinical trial results.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 11, 2023
We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session
September 11, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly
September 10, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
Biotech Stock Crinetics Pharmaceuticals Positioned For Success In Chronic Endocrine Disorder Treatment, Says Analyst
August 31, 2023
Oppenheimer initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) with an Outperform rating
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via
Benzinga
Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 08, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023
June 21, 2023
From
Crinetics Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.